Federated Hermes
AUPH icon

Federated Hermes’s Aurinia Pharmaceuticals AUPH Stock Holding History

Federated Hermes’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.37M Buy
80,994
+14,201
+21% +$227K ﹤0.01% 1077
2026
Q1 		$990K Sell
66,793
-79
-0.1% -$1.16K ﹤0.01% 1120
2025
Q4 		$1.07M Sell
66,872
-14
-0% -$198 ﹤0.01% 1103
2025
Q3 		$739K Sell
66,886
-129
-0.2% -$1.41K ﹤0.01% 1233
2025
Q2 		$568K Buy
67,015
+27
+0% +$216 ﹤0.01% 1304
2025
Q1 		$539K Buy
66,988
+17,629
+36% +$143K ﹤0.01% 1282
2024
Q4 		$443K Buy
49,359
+49,355
+1,233,875% +$403K ﹤0.01% 1347
2024
Q3 		$29 Buy
4
+3
+300% +$19 ﹤0.01% 2033
2024
Q2 		$6 Hold
1
– – ﹤0.01% 2010
2024
Q1 		$5 Buy
+1
New +$7 ﹤0.01% 2010
2023
Q1 		– Sell
-80,481
Closed -$348K – 2123
2022
Q4 		$348K Buy
80,481
+80,174
+26,115% +$465K ﹤0.01% 1448
2022
Q3 		$2K Sell
307
-127,490
-100% -$1.1M ﹤0.01% 1960
2022
Q2 		$1.28M Buy
127,797
+19,496
+18% +$218K ﹤0.01% 1051
2022
Q1 		$1.34M Buy
108,301
+81,716
+307% +$1.26M ﹤0.01% 1149
2021
Q4 		$608K Sell
26,585
-47,231
-64% -$1.12M ﹤0.01% 1429
2021
Q3 		$1.63M Sell
73,816
-85,710
-54% -$1.36M ﹤0.01% 1101
2021
Q2 		$2.07M Buy
159,526
+30,318
+23% +$386K ﹤0.01% 1085
2021
Q1 		$1.68M Buy
129,208
+15,176
+13% +$220K ﹤0.01% 1173
2020
Q4 		$1.58M Buy
114,032
+8,015
+8% +$117K ﹤0.01% 1155
2020
Q3 		$1.56M Buy
+106,017
New +$1.54M ﹤0.01% 1078

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Federated Hermes's AUPH Position: Q2 2026 in Review

Federated Hermes increased its Aurinia Pharmaceuticals (AUPH) stake by 21% in Q2 2026, buying an estimated $227K and bringing the position to 80,994 shares worth $1.37M. The position accounts for ﹤0.01% of the portfolio, ranked #1077.

Federated Hermes first reported a position in AUPH in Q3 2020 and has held it in 20 quarters since. The position peaked at $2.07M in Q2 2021. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Federated Hermes held 80,994 shares of Aurinia Pharmaceuticals worth $1.37M as of Q2 2026.
  • Federated Hermes bought 14,201 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $227K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1077 holding.
  • Federated Hermes first reported a position in Aurinia Pharmaceuticals in Q3 2020 and has held it in 20 quarters since.
  • Federated Hermes's Aurinia Pharmaceuticals position peaked at $2.07M in Q2 2021.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.